Home > Insider Trading > Filing (0001144204-19-037023)

Filing Details

Accession Number:: 0001144204-19-037023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-31 21:43:14
Reporting Period:: 2019-07-29

Accepted Time:: 2019-07-31 21:43:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1447362	Castle Biosciences Inc	CSTL	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1435183	Garheng Kong	C/O Healthquest 1301 Shoreway Road, Suite 350 Belmont CA 94002	No	No	Yes	No
1579382	Sofinnova Healthquest Partners, L.p.	C/O Healthquest 1301 Shoreway Rd, Suite 350 Belmont CA 94002	No	No	Yes	No
1783696	Healthquest Venture Management, L.l.c.	C/O Healthquest 1301 Shoreway Road, Suite 350 Belmont CA 94002	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-07-29	1,676,061	$0.00	1,676,061	No	4	C	Direct
Common Stock	Acquisiton	2019-07-29	83,453	$12.80	1,759,514	No	4	C	Direct
Common Stock	Acquisiton	2019-07-29	11,572	$0.02	1,771,086	No	4	X	Direct
Common Stock	Disposition	2019-07-29	9	$16.00	1,771,077	No	4	S	Direct
Common Stock	Acquisiton	2019-07-29	62,500	$16.00	1,833,577	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	S	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-07-29	19,524	$0.00	16,015	$0.00
Common Stock	Series E-2 Preferred Stock	Disposition	2019-07-29	436,910	$0.00	358,416	$0.00
Common Stock	Series E-3 Preferred Stock	Disposition	2019-07-29	388,669	$0.00	318,842	$0.00
Common Stock	Series F Preferred Stock	Disposition	2019-07-29	1,198,016	$0.00	982,785	$0.00
Common Stock	Convertible Promissory Note	Disposition	2019-07-29	0	$0.00	83,453	$12.80
Common Stock	Warrant to Purchase Series F Preferred Stock	Disposition	2019-07-29	14,107	$0.00	11,572	$0.02

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Direct
	No	4	C	Direct
	No	4	C	Direct
	No	4	C	Direct
	No	4	C	Direct
2019-07-29	No	4	X	Direct

Footnotes

The shares of Common Stock issued upon conversion of the Preferred Stock were calculated by first aggregating all series of Preferred Stock held by HealthQuest, in accordance with the terms of the Company's then-effective Certificate of Incorporation.
Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.
The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.
The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share.
On July 29, 2019, HealthQuest exercised a warrant to purchase 11,572 shares of the Issuer's common stock for approximately $0.02 per share. HealthQuest paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 9 of the warrant shares to pay the exercise price and issuing to HealthQuest the remaining 11,563 shares.
Represents a purchase from the underwriters in the Issuer's IPO.
Immediately prior to the closing of the IPO, the warrant became exercisable for 11,572 shares of common stock.
Immediately exercisable.